Correspondance with management thread, page-28

they will need a cr in q3 there is no doubt.  but if the trials go through they could get bought out or at least have value hold post cr.  revenue will be tough sleddin even if the trials go through though; its just gonna take time for doctors to care.  u gotta pay them off and pay off the distributors and everyone gets their chunk of the pie.  suprised they didnt pick up the health and wellness sector and lobby for it in new zealand and australia and that area.  i think botanical extracts seem to be much more of a health and wellness product than a medicine but of course as a health and wellness product it works for some pain; some sleep and some other things.  i think the best hope is they get bought out after successful trials for 400-600m.  not sure what the shares are here but i think that would be around 50-60 cents.  that is best case.  could be worth a gamble.  i think anxiety though will be the big winner for medical.  good luck.